Evidence map›Paper›PMID 31551380›Full record

Observational studyBMJ open2019

Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study.

Anne Brédart, Jean-Luc Kop, Julia Dick, Alejandra Cano, Antoine De Pauw, Amélie Anota, Joan Brunet, Peter Devilee, Dominique Stoppa-Lyonnet, Rita Schmutzler and 1 more

Abstract readObservational Study
In one paragraph

Observational study in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Observational
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anne BrédartDepartment of Supportive Care, Psycho-Oncology Unit, Institut Curie, Paris, France anne.bredart@curie.fr.ORCID 0000-0002-1864-5371
Jean-Luc KopDépartement de Psychologie, Université de Lorraine, 2LPN (CEMA), Nancy, France.
Julia DickFamilial Breast and Ovarian Cancer Centre and Faculty of Medicine, Cologne University Hospital, Cologne, Germany.
Alejandra CanoClinical and Health Psychology Department, University Autónoma of Barcelona, Barcelona, Spain.
Antoine De PauwCancer Genetic Clinic, Institut Curie, Paris, France.
Amélie AnotaFrench National Quality of Life in Oncology Platform, and Methodology; Quality of Life in Oncology Unit, University Hospital of Besançon, Besançon, France.
Joan BrunetMedical Oncology Department, Catalan Institute of Oncology, Barcelona, Spain.
Peter DevileeDivision of Pathology; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Dominique Stoppa-LyonnetCancer Genetic Clinic, Institut Curie, Paris, France.
Rita SchmutzlerFamilial Breast and Ovarian Cancer Centre and Faculty of Medicine, Cologne University Hospital, Cologne, Germany.
Sylvie DolbeaultDepartment of Supportive Care, Psycho-Oncology Unit, Institut Curie, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

OBJECTIVES AND

settingAdvances in multigene panel testing for cancer susceptibility has increased the complexity of counselling, requiring particular attention to counselees' psychosocial needs. Changes in psychosocial problems before and after genetic testing were prospectively compared between genetic test results in women tested for breast or ovarian cancer genetic susceptibility in French, German and Spanish clinics. PARTICIPANTS AND MEASURES: Among 752 counselees consecutively approached, 646 (86%) were assessed after the initial genetic consultation (T1), including 510 (68%) affected with breast cancer, of which 460 (61%) were assessed again after receiving the test result (T2), using questionnaires addressing genetic-specific psychosocial problems (Psychosocial Aspects of Hereditary Cancer (PAHC)-six scales). Sociodemographic and clinical data were also collected.

resultsSeventy-nine (17.2%), 19 (4.1%), 259 (56.3%), 44 (9.6%) and 59 (12.8%) women received a

conclusionsIn women tested for breast or ovarian cancer genetic risk in European genetics clinics, psychosocial problems were mostly unaffected by genetic testing. Apart from women receiving a VUS result, those with another test result presented unchanged needs in counselling in particular about hereditary predisposition and familial/social issues.

Indexed as

Adaptation, PsychologicalGenetic CounselingHereditary Breast and Ovarian Cancer SyndromeSocial BehaviorAdultBRCA1 ProteinFemaleFranceGenetic Predisposition to DiseaseGenetic TestingGermanyHumansPsychologySpainStress, PsychologicalBRCA1 ProteinBRCA1 protein, humanhereditary breast and ovarian cancermultigenepsychosocial problemsservice deliverytargeted testing

Identifiers

PMID31551380
PMCPMC6773290

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.